New vaccine approach for hepatitis C “C” won “ConsolationIST” award
Hernando A.
The Macedo Lab is based at the University of Oxford and has been working intensively with partners for the last 10 years on viruses with currently known gene ends.
“To our surprise, when we started to draw conclusions about the efficacy and tolerability of this approach, it was the case that was already in use throughout Europe: Avigan or Nipah virus, Cuba virus, Culex virus and Portland virus among others.”
The expert group stresses that it is a Polish or international consortium addition, and that the Macedo Lab would continue to work collaboratively with different grantees and governments.